Cite
"Non-Invasive System And Method For Detecting And Accurately Quantifying Subclinical And Clinical Systolic And Diastolic Heart Failure" in Patent Application Approval Process (USPTO 20240008837).
MLA
“‘Non-Invasive System And Method For Detecting And Accurately Quantifying Subclinical And Clinical Systolic And Diastolic Heart Failure’ in Patent Application Approval Process (USPTO 20240008837).” Cardiovascular Week, Jan. 2024, p. 1072. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175043732&authtype=sso&custid=ns315887.
APA
“Non-Invasive System And Method For Detecting And Accurately Quantifying Subclinical And Clinical Systolic And Diastolic Heart Failure” in Patent Application Approval Process (USPTO 20240008837). (2024). Cardiovascular Week, 1072.
Chicago
“‘Non-Invasive System And Method For Detecting And Accurately Quantifying Subclinical And Clinical Systolic And Diastolic Heart Failure’ in Patent Application Approval Process (USPTO 20240008837).” 2024. Cardiovascular Week, January, 1072. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175043732&authtype=sso&custid=ns315887.